Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Idea Of The Day -- Ignore unavailable to you. Want to Upgrade?

To: IQBAL LATIF who wrote (16453)	1/16/1998 3:33:00 PM
From: AlienTech	Read Replies (1) \| Respond to of 50167

BOSTON SCIENTIFIC (BSX) 46 7/8 +3 13/16. Wall Street analysts are a quirky bunch. Some of their moves simply make you scratch your head. For example, this medical device maker's shares have risen as much as 5 7/8 points, or 13%, today, after the company released preliminary sales numbers for the 4th qtr. For the qtr ended December 31, BSX's sales rose 14% to $493 million. On the news, several analyst repeated their buy ratings on the stock, even though the sales growth figure is below the majority of their forecasts. So what gives? Well, excluding the effect of foreign exchange, the company's revenues would have risen 19%. That's great. But this is the real world we're living in. Dealing with currency fluctuations is a fact of life if one does business overseas. You can be sure, that had the dollar been falling... You know the rest. Yes, it's pretty incredible how one-sided this game tends to be.